SEARCH

SEARCH BY CITATION

Keywords:

  • Gut motility;
  • infection;
  • inflammation;
  • immune response;
  • smooth muscle

Summary

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

Alteration in gastrointestinal (GI) motility occurs in a variety of clinical settings which include acute enteritis, inflammatory bowel disease, intestinal pseudo-obstruction and irritable bowel syndrome (IBS). Most disorders affecting the GI tract arise as a result of noxious stimulation from the lumen via either microbes or chemicals. However, it is not clear how injurious processes initiated in the mucosa alter function in the deeper motor apparatus of the gut wall. Activation of immune cells may lead to changes in motor-sensory function in the gut resulting in the development of an efficient defence force which assists in the eviction of the noxious agent from the intestinal lumen. This review addresses the interface between immune and motor system in the context of host resistance based on the studies in murine model of enteric nematode parasite infection. These studies clearly demonstrate that the infection-induced T helper 2 type immune response is critical in producing the alterations of infection-induced intestinal muscle function in this infection and that this immune-mediated alteration in muscle function is associated with host defence mechanisms. In addition, by manipulating the host immune response, it is possible to modulate the accompanying muscle function, and this may have clinical relevance. These observations not only provide valuable information on the immunological control of gut motor function and its role in host defence in enteric infection, but also provide a basis for understanding pathophysiology of gastrointestinal motility disorders such as in IBS.


Introduction

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

The majority of disorders afflicting the gastrointestinal (GI) tract arise as a result of noxious stimulation from the lumen, via either microbes or chemical. Conditions ranging from infective acute enteritis or colitis to chronic inflammatory bowel diseases (IBDs) and functional disorders such as irritable bowel syndrome (IBS) are accompanied by altered motility. However, in the absence of any major structural abnormality such as an obstruction or deep ulceration, it is unclear how injurious processes initiated in the mucosa change function and/or structure in the deeper neuromuscular layers. For the most part, overt responses to noxious stimuli result in an inflammatory response that is usually limited to the mucosal compartment and may result in innate and adaptive immune responses. Interaction between adaptive and innate components of immune response is required to play an effective total response against any invading agent. Activation of immune cells may lead to changes in motor-sensory function in the GI tract resulting in the development of an efficient defence force which assist in the eviction of the noxious agent from the intestinal lumen. This review will address the studies on immunological basis of altered GI motor function in the context of host resistance in enteric infection, providing linkage between a variety of clinically relevant pathophysiological processes and the development of various symptoms reflecting changes in the neuro-muscular tissues of the gut wall such as pain, bloating, distension, vomiting, diarrhoea, and constipation. These studies have been performed using animal models to generate new concepts regarding the relationship between immune system and neuromuscular tissues, and to develop models reminiscent of several important functional GI disorders.

Clinical point of view

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

Among the GI illness, functional disorders are the most common category which consists of entities like IBS and functional dyspepsia. They are characterized by disorders of function with preservation of the structural integrity of the GI tract. This definition does not, however, rule out subtle quantitative or qualitative changes in the cellularity of the lamina propria or, indeed, in the deeper neuromuscular tissues that are seldom, if ever, accessed through biopsies. IBS is a very common condition, and is as likely to be heterogeneous in its pathogenesis as it is in its clinical presentation. Two major mechanisms may interact in this disorder: altered GI motility and increased sensitivity [1,2]. Altered motility in IBS includes changes in whole gut transit, colonic propagating contractions, and ascending and transverse colon emptying [3]. Recent work has emphasized the role of acute gastroenteritis as a precipitating factor in the development of a chronic IBS–like syndrome termed postinfective IBS [4,5]. It has been suggested based on retrospective analysis that up to one-third of all IBS patients may have had an acute infection to precipitate their symptoms. In addition, there is evidence of subclinical inflammation and immune activation in the mucosa of some patients with IBS, and this is not necessarily restricted to those patients with an infective aetiology [6]. In overt inflammatory conditions of the bowel, such as Crohn's disease and ulcerative colitis, there have been longstanding observations of altered motility and intestinal muscle contractility [7,8]. Chronic intestinal pseudo-obstruction is another GI illness represented by chronic intestinal dilatation and dysmotility in the absence of mechanical obstruction or inflammatory disease [9,10].

Under normal circumstances, inflammatory or immune cells are found infrequently in the neuromuscular tissues of gut. Yet, it is evident that in conditions associated with overt inflammation (Crohn's disease or ulcerative colitis), in pseudo-obstruction and in cases of severe IBS, these tissues become infiltrated to varying degrees, by immune cells with a particular predilection, it appears, for lymphocytes. The remainder of this review will address the findings obtained from the studies in animal model on the influence of immune cells in the context of host resistance.

Experimental studies

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

Models of nematode parasite infection are of considerable importance in exploring the pathophysiology of many GI disorders and over the past decade our laboratory has used primary infection of rats or mice with the nematode Trichinella spiralis as a model to study the interface between the immune and motor systems. The choice of this model is based on the existence of an extensive literature regarding the inflammatory and immune responses to this parasite (Table 1), and by the fact that many of the ingested parasites in this model are eventually evicted from the gut. That is, they retain their viability and fecundity. Thus, in large part, a process of expulsion occurs and this forces attention on the role of the motor system in promoting the expulsion of these parasites from the intestine. Indeed, earlier studies showed that in segments of extrinsically denervated intestine taken from animals with a primary infection with the nematode parasite T. spiralis, when examined ex vivo following extrinsic denervation, demonstrated clear-cut and enhanced propulsive motor activity [11]. This finding showed that the enhanced propulsive power of the motility apparatus has its origin, at least in part, in the tissues intrinsic to the gut wall, thus implicating enteric nerves and muscle. These observations provided the platform for embarking on a series of in vitro experiments designed at understanding the interface between activation of the mucosal immune system by this parasite, and the resulting changes in enteric muscle function.

Table 1.  Advantages of animal model of T. spiralis.
Widely used nematode model for understanding inflammatory changes and host defence.
Biology and host immunity well defined.
Presence of natural biological end point in the eviction of parasites from the gut.
Distinct Th2 type immune response is useful to understand the immune regulation of gut physiological changes.
Altered motility is associated with the primary infection.

The measurement of muscle contraction as a surrogate marker of intestinal motility

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

The final common pathway in the regulation of intestinal motility is the contractility of intestinal muscle. This can be easily evaluated in vitro using a longstanding tissue bath approach. Intestinal muscle strips are suspended along a longitudinal axis in an organ bath containing oxygenated Kreb's buffer. The strips are attached at one end to a force transducer and responses are recorded on a polygraph. By incremental increase in the stretch applied in the longitudinal axis of the muscle, the optimum tension of contractile studies is determined and the tissue is then exposed to various agonists or antagonists and isometric contraction assessed. Clearly, changes in contractility observed in vitro cannot be extrapolated directed into the in vivo situation. Consideration must be made of the influences of enteric nerves, the interstitial cells of Cajal, and endocrine factors. In addition, the roles of circular and longitudinal muscle differ in terms of their contribution to peristaltic activity. Nevertheless, muscle contractility is an acceptable and convenient method of assessing how inflammatory and immune cells alter this component of intestinal motility.

Initial studies by Vermillion & Collins [12] from our laboratory clearly show a significant enhancement in intestinal muscle contractility in response to carbachol during primary infection of rats with T. spiralis (Fig. 1). Subsequent studies in mice also revealed a significant increase in intestinal muscle contractility following T. spiralis infection [13]. In applying this technique to studies on infection-induced changes in contractility, notice is taken of the hyperplasia and hypertrophy of muscle seen in this model [14]. Thus, force generation is expressed by unit cross-sectional area of the muscle along the axis of the contraction.

image

Figure 1. Response of intestinal muscle from control and T. spiralis infected rats. (a) Dose–response relationships for carbachol-induced tension generation by intestinal muscle from control non-infected (○) and T. spiralis infected (●) rats. Rats were infected orally with T. spiralis and killed at day 6 postinfection [12]. (b) Light micrographs of cross sections of muscularis externa of rat jejunum before and after T. spiralis infection, showing increased size of longitudinal and circular smooth muscle layers in the inflamed jejunum [14].

Download figure to PowerPoint

Relationship between inflammatory response and alteration in intestinal muscle contractility

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

To address the question of whether the alterations in muscle contractility during infection occur as a result of the presence of parasites in the gut or the host's inflammatory response to them, T. spiralis infected rats were treated with corticosteroid and the myeloperoxidase (MPO) activity was investigated to evaluate the inflammatory response in the mucosa. MPO is an enzyme contained in the azurophilic granules of neutrophils and other myeloid cells and is commonly used as an index of neutrophil infiltration and acute inflammation [15]. Treatment with corticosteroid inhibited the increase of MPO activity following infection and this was accompanied by an attenuation of intestinal muscle contractility [16]. This study implicates that the inflammatory process rather than the parasite as the cause of altered intestinal muscle contractility.

Immunological basis for altered intestinal muscle function

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

Role of innate immune response

Macrophages

Macrophages are the sentinels of the immune system. These cells perform a key role in innate defence against foreign invaders and modulate adaptive immune responses. In addition, macrophages produce a number of cytokines (low molecular weight proteins secreted from various cells which regulate the immune response) like interleukin (IL)-1, IL-6 and TNF-α, which play a variety of roles in nonspecific body defence. Macrophages infiltrate the gut including the neuromuscular layers during T. spiralis infection in mice and there is increased expression of pro-inflammatory cytokines IL-1β, TNF-α and IL-6.

To determine the role of macrophages in the induction of muscle hyper-contractility, the experimental strategy was to deplete intestinal macrophages and observe whether this affected the generation of muscle hyper-contractility in infected mice. Liposomes (artificially prepared lipid vesicles) were used to encapsulate dichloromethylene diphosphate (clodronate, Cl2MDP), which induces the apoptosis of macrophages [17]. Treatment of mice with clodronate containing liposomes effectively depleted macrophages and attenuated the inflammatory response to T. spiralis infection. However, muscle hyper-contractility was unaffected, implying that macrophages are not critical for the change in muscle contraction [18].

NK T cells

NK T cells are an unusual population of T cells, which coexpress receptors for T and NK cells, and these cells are considered to be a source of early IL-4 [19]. Murine CD1d1 has been implicated in the development and function of NK T cells [20]. Recently we have investigated the intestinal muscle contractility and host protective immunity during T. spiralis infection in CD1d1 mutant mice, which are deficient of NK T cells. Preliminary data suggest that absence of NK T cells in CD1d1–/– mice is associated with the reduction of infection-induced muscle hypercontractility and IL-4 in the early stage of this nematode infection [21].

Role of adaptive immune response

T cells

T lymphocytes are crucial in many immune responses, including those associated with intestinal nematode infection. Previous studies have demonstrated the infiltration of muscle layers by T lymphocytes during T. spiralis infection and ultrastructural analysis revealed close communication between lymphocytes and muscle cells indicating the possibility of a direct interaction between these cell types [22].

To investigate the role of T cells, we used mice that were either deficient in T cells (athymic mice), or in T helper cells (CD8+ or CD4+ cell deficient mice) or where incapable of T cell activation by virtue of the absence of the major histocompatibility complex II (MHC II) [23,24]. Infection induced intestinal muscle hypercontractility is T cell dependent because changes were attenuated from infected athymic mice and this was accompanied by reduced parasite expulsion, indicating the presence of a common immunological basis in muscle function and worm expulsion in this model. The role of CD8+ T cells seems to be not significant as there was no difference in the development of infection induced intestinal muscle hypercontractility and in worm expulsion between CD8 deficient and wild type mice. However, CD4+ T cells appeared to play a role, since CD4 deficient mice exhibited reduced muscle contractility. MHC II deficient mice showed greatest attenuation in the development of muscle contractility and also exhibited noticeably delayed worm expulsion. Reconstitution of T cell function in athymic mice by injecting splenic lymphocytes from euthymic mice prior to infection with T spiralis restored intestinal muscle hypercontractility and normal worm expulsion from the gut. To examine the role of CD4+ cells further, MHC II deficient mice were reconstituted with purified CD4+ T cells and the effect on intestinal muscle contractility was assessed following infection. The partial restoration of muscle hypercontractility during subsequent infection identified a role for T helper cells.

Th1/Th2 cells

In association with MHC II molecules, antigen presenting cells (APC) present antigens to CD4+ T helper (Th) cells. Th cell-dependent immune responses are generally divided into two major subsets, Th1 and Th2 [25]. Th1 cells predominantly produce IFN-γ and IL-2,while Th2 cells produce IL-4, IL-5, IL-9, and IL-13. Th1 and Th2 cross regulate one another. IFN-γ secreted by Th1 cells directly suppresses IL-4 production and thus inhibits the differentiation of naïve Th cells into Th2 cells. In contrast, IL-4 and IL-10 inhibit the secretion of IL-12 and IFN-γ, blocking the polarization into Th1 cells. Th2 type of immune response is predominantly associated with protective immunity in nematode infection. Although IL-4 is the key cytokine in the development of Th2 type immune responses, recent studies suggest the involvement of another closely related cytokine, IL-13 [26]. IL-4, and IL-13 share the alpha chain of IL-4 receptor and occupation of this receptor results in the activation of signalling pathway involving the activation of signal transducer and activator of transcription factor 6 (Stat6) through phosphorylation by Janus kinases 1 and 3 [27]. Once activated, Stat6 proteins form homodimers, translocate to the nucleus, and bind to promoter regions to regulate gene transcription. Studies using Stat6 deficient (Stat6–/–) mice clearly indicate that the Stat6 pathway is critical in the differentiation of Th cells towards Th2 phenotype [28]. To determine whether a similar pathway is involved in mediating muscle hypercontractility in this model, we studied Stat6 –/– mice to investigate T. spiralis-induced muscle contractility. We observed marked attenuation in infection-induced intestinal muscle contractility in Stat6–/– mice compared with the wild type mice (Fig. 2) and this was accompanied by delayed worm expulsion from the intestine [29]. We were also able to demonstrate the presence of IL-4 and IL-13 in the muscularis externa layer during the primary infection with T. spiralis and IL-4R alpha in the dispersed intestinal muscle cells [29,30]. These observations indicated that Th2 cytokines, IL-4 and IL-13, acting via Stat6, mediate the development of nematode infection induced intestinal muscle hypercontractility and that this, in turn contributes to the worm expulsion process.

image

Figure 2. (a) Intestinal muscle contraction and cytokine response in T. spiralis infected Stat6 deficient (Stat6–/–) and wild type (Stat6+/+) mice [29]. (b) Cytokines gene expression in muscularis externa of uninfected control (lanes 1–3) and T. spiralis-infected (lanes 4–6) mice. C57BL/6 mice were infected with T. spiralis orally and killed on day 6 p.i. to investigate expression of the IL-4, IL-13, and IFN-γ genes [29]. (c) IL-4 receptor (IL-4R) mRNA expression in dispersed longitudinal smooth muscle cells from control and T. spiralis-infected mice. sIL-4R, soluble IL-4R; mIL-4R, membrane IL-4R [30].

Download figure to PowerPoint

Very recently it has been reported that IL-4 and IL-13 play an important role in the generation of intestinal muscle contractility in mice infected with N. brasiliensis and Heligosomoides polygyrus[31] further supporting our hypothesis that Th2 responses mediate muscle contractility in nematode infection.

To evaluate the role of another Th2 cytokine, IL-9, we used the strategy of immunoneutralization. We observed that although administration of exogenous IL-9 improved infection induced intestinal muscle contractility and worm expulsion in T spiralis infection, neutralization of endogenous IL-9 had no significant effect on muscle contraction and worm expulsion [32]. Taken together these observations show that although a Th2 immune response is critical for the expression of muscle hypercontractility in T. spiralis infection, not all Th2 cytokines are involved; IL-4 and IL-13 play critical roles whereas IL-9 does not.

To further evaluate the role of Th1/Th2 in infection-induced alteration of enteric muscle function, studies were done to investigate the effect of the over expression of IL-12 on intestinal muscle contractility and on worm expulsion in T. spiralis infected mice. IL-12 is a key cytokine in the differentiation of CD4+ Th cells toward Th1 associated responses by stimulating production of IFN-γ by Th and natural killer cells (33). It has been reasoned that if the Th2 response is critical for both the development of changes in intestinal muscle function and the expulsion of the worms, then shift of the Th2 response towards Th1 response should not only prolong the infection but also attenuate infection-induced muscle hypercontractility. Indeed, that is the case and a shift to Th1 response by over expression of IL-12 significantly altered intestinal muscle hypercontractility in this Th2 based enteric infection (34). Recombinant adenovirus vector was used for transferring and over expressing IL-12 gene. Adenovirus vector is replication deficient vector and is highly infectious and effectively express high level of target gene. IL-12 gene transfer using a single injection of recombinant adenovirus vector expressing IL-12 (Ad5IL-12) in T. spiralis infected mice effectively inhibited the development of infection-induced intestinal muscle hypercontractility and prolonged worm survival in the gut. This was accompanied by up regulation of the Th1 cytokine IFN-γ and down regulation of Th2 cytokine IL-13 in the muscularis externa of the intestine and increased IFN-γ production and decreased IL-4 and IL-13 production from in vitro stimulated spleen and mesenteric lymph node cells. These findings strongly suggest that intestinal muscle hypercontractility and worm expulsion share a common immunological basis regulated by Th2 type immune response and may be causally linked.

Role of CD40–CD40 ligand interaction

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

The interaction between CD40 ligand (CD40L) on T cells and CD40 on antigen presenting cells has been shown to regulate both humoral and cellular immune responses [35,36]. To understand the initial events linking infection to the development of muscle hypercontractility we recently examined the contribution of CD40–CD40L interaction in the development of intestinal muscle hypercontractility, monocyte chemoattractant protein-1 (MCP-1) production and in the Th2 response in CD40L deficient (CD40L –/–) mice infected with T. spiralis. Expulsion of intestinal worms was substantially delayed in CD40L –/– mice as compared to the wild-type mice following T. spiralis infection. Consistent with delayed worm expulsion, there was a significant attenuation of intestinal muscle contractility in CD40L–/– mice [37]. Infected CD40L –/– mice also exhibited marked impairment in production of MCP-1 and Th2 cytokine production. These data suggest that the early events leading to the generation of Th2 response include CD40–CD40 ligand interaction, which subsequently influences the production of Th2 cytokines most likely via up-regulation of MCP-1. Recently it has been reported that in the MCP-1 deficient mice worm expulsion is inhibited during infection with T. muris and this was associated with a shift of immune response towards Th1 type from Th2 type [38]. Together these findings strongly suggest that intestinal muscle hypercontractility and worm expulsion share a common immunological basis regulated by Th2 type immune response and may be causally linked.

Role of intestinal muscle hypercontractility in host defence

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

Previous studies from our laboratory have shown that the inflammation-induced intestinal muscle hypercontractility is prominent in the proximal part of the intestine and that the distal parts such as the ileum and colon exhibit reduced muscle contractility [39]. Therefore, it seems very likely that the distribution of changes would create an aboral gradient in muscle tension generation during infection, enhancing aboral propulsion of luminal contents. If such forces contribute to the host defence against parasite infection, then one might expect to see a relationship between the magnitude of intestinal muscle hypercontractility and the ability of the host to evict the parasites from the gut. This is indeed the case, with strong responder to T. spiralis infection such as NIH Swiss mice which expel the parasite faster exhibiting the greater degree of muscle contractility and slow responders such as B10.BR mice which expel the parasite slowly exhibiting lesser degree of hypercontractility [13]. These observations strengthened the association between host defence and changes in muscle function and prompted a closer observation of the underlying immune-mediated mechanisms involved in the alteration of intestinal muscle contractility. Studies involving Stat6 deficient mice and IL-12 gene transfer mediated switching of immune response towards Th1 type clearly demonstrate that Th2 type response is critical in the development of infection-induced intestinal muscle hypercontractility and efficient worm expulsion. It seems likely that cytokines specifically IL-4 and IL-13 from the Th2 type cells influence the second message system of muscle cells by acting either on the calcium channel or on muscuranic receptor, which subsequently alter the intestinal muscle contractility and this alteration of contractility is associated with enhanced parasite eviction. Recently we have investigated a causal link between these responses by administering opiate (buprenorphine) to attenuate muscle hypercontractility in T. spiralis infection, and determined whether this delayed worm expulsion without attenuating the Th2 response. Results show marked inhibition of worm expulsion and intestinal muscle hypercontractility without impairing IL-4 response, supporting our hypothesis that altered motility plays an important role in host defence in this model [40]. Taken together, these studies clearly indicate that the motor apparatus of the gut is subject to modulation by the immune system and subsequently plays an important role in host defence.

Schematic representation of the interaction among mucosal inflammation, immune activation and gut motility in the defence of gut against injurious agents has been depicted in Fig. 3. Based on these studies it can be concluded that trigger in mucosal inflammation seems to recruit physiological systems such as the motor apparatus via immune activation to assist in the host defence.

image

Figure 3. Conceptual model of the interface between the immune and motor systems in the gastrointestinal (GI) tract, and the putative role of this interface in host defence. Infection produces mucosal injury and inflammation and induces an immune response. The Th2 type immune response induces changes in the intestinal muscle contractility in response to physiological stimuli such as the release of acetylcholine from the enteric nerves. The resulting increase in propulsive forces contributes to the eviction of the infective agent from the GI tract. Not shown are other components of motility apparatus including other enteric nerves, interstitial cells of Cajal and enteroendocrine cells.

Download figure to PowerPoint

Inflammation and motility in other experimental models

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

In addition to the findings observed in the nematode infections there are several other experimental models which clearly show interaction between inflammation and motility. Intestinal hypomotility and delayed gastric emptying have been shown to be characteristic in a mouse model of postoperative ileus [41]. This condition is the result of intestinal inflammation due to activation of macrophages [42,43] that are triggered by bowel manipulation. Recently it has been shown that peri-operative stimulation of the vagus nerve prevented this manipulation-induced inflammation of the intestine and ameliorated postoperative ileus and this effectiveness of vagal stimulation in reducing intestinal inflammation depended on activation in macrophages in the intestinal muscularis [44]. It has been also shown that leucocyte-derived inducible nitric oxide (NO) plays an important role in the generation of intestinal inflammation and inhibits GI motility after manipulation in this model of ileus [45]. In the rat model of haemorrhagic shock it has been also shown that induced NO contributes to the inflammatory changes in the gut wall and participates in the activation of cytokine expression that regulate impaired gut motility [46]. Communication between inflammation and gut motility is also demonstrated in relation to carbon monoxide (CO), the end product of the anti-inflammatory endogenous haeme oxygenase 1 (HO-1) pathway. Inhalation of CO significantly down-regulated IL-6, IL-1β and inducible NO response and improved post-transplant dysmotility in the syngeneic rat transplant model [47]. In hapten (2,4,6-trinitrobenzene sulphonic acid; TNBS)-mediated model of experimental colitis an attenuation of muscle contractility was observed in association with inflammation and Th1 immune response [48,49].

These observations clearly suggest that inflammation of GI tract causes significant alteration in gut motor function and the immunological profile of the inflammatory response may be an important determinant of these changes that occur in each model.

Implications

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References

These studies have generated a number of concepts that provide insight into how the immune and motor systems of the gut interface. First, these studies clearly demonstrate that the inflammation of the mucosa causes changes in the muscle function in the GI tract. This is particularly important when considering widespread disturbances in muscle contractility and other aspects of gut physiology occur in a variety of clinical settings associated with inflammation and immune activation which include IBS and IBD. Another concept that has emerged is that the immunological profile of the inflammatory response is an important determinant of the changes in muscle function that occur in each model. Th2 type immune response associated with enteric parasitic infection play a pivotal role in the regulation of intestinal muscle hypercontractility and this is associated with host resistance. This corroborates with the studies in asthma where Th2 cells and their cytokines are identified as critical component in the development of airway hyper reactivity in atopic and intrinsic asthmatics [50,51]. From our laboratory it has been also shown that in a model of postinfectious IBS based on primary T. spiralis infection changes in neuromuscular function initiated by the infection can persist long after the clearance of the infection and resolution of the inflammatory changes in the mucosal compartment [52]. It has been also demonstrated that while the initial immunological (Th2) response is required for induction of the neuromuscular changes, they are not required for the maintenance of these changes postinfection. The state of persistent dysfunction of the neuromuscular tissue is maintained by the production of mediators such as TGF-β and prostaglandin E2 by intestinal muscle [53,54]. Thus, in the postinfective or inflammatory state, the maintenance of tissue dysfunction is maintained by production of mediators by resident cells such as muscle cells. Another concept that emerged is that manipulation of host immune response is able to modulate the accompanying motor changes, and this may have clinical relevance in the conditions associated with altered GI motility. Understanding the underlying immunological basis of altered GI motor function and its role in host defence, coupled with the ability to modulate by immune responses as depicted in our studies, may ultimately lead to new therapeutic strategies in GI functional and inflammatory disorders.

References

  1. Top of page
  2. Summary
  3. Introduction
  4. Clinical point of view
  5. Experimental studies
  6. The measurement of muscle contraction as a surrogate marker of intestinal motility
  7. Relationship between inflammatory response and alteration in intestinal muscle contractility
  8. Immunological basis for altered intestinal muscle function
  9. Role of CD40–CD40 ligand interaction
  10. Role of intestinal muscle hypercontractility in host defence
  11. Inflammation and motility in other experimental models
  12. Implications
  13. Acknowledgements
  14. References
  • 1
    Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002; 122: 203248.
  • 2
    Mert HR. Irritable bowel syndrome. N Engl J Med 2003; 349: 213646.
  • 3
    Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 65268.
  • 4
    Spiller RC. Post infectious irritable bowel syndrome. Gastroenterology 2003; 124: 166271.
  • 5
    Collins SM, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut 2001; 49: 7435.
  • 6
    Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 177883.
  • 7
    Vermillion, DL, Huizinga JD, Riddell RH et al. Altered small intestinal smooth muscle function in Crohn's disease. Gastroenterology 1993; 104: 16929.
  • 8
    Snape WJ Jr, Williams R, Hyman PE. Defect in colonic smooth muscle contraction in patients with ulcerative colitis. Am J Physiol 1991; 261: G98791.
  • 9
    Di Lorenzo. Pseudo-obstruction: current approaches. Gastroenterology 1999; 116: 9807.
  • 10
    Hirano I, Pandolfino J. Chronic intestinal pseudo-obstruction. Dig Dis 2000; 18: 8392.
  • 11
    Alizadeh H, Castro GA, Weems WA. Intrinsic jejunal propulsion in the guinea-pig during parasitism with Trichinella spiralis. Gastroenterology 1987; 93: 78490.
  • 12
    Vermillion DL, Collins SM. Increased responsiveness of jejunal longitudinal muscle in Trichinella-infected rats. Am J Physiol 1988; 264: G124G129.
  • 13
    Vallance BA, Blennerhassett PA, Collins SM. Increased intestinal muscle contractility and worm expulsion in nematode infected mice. Am J Physiol 1997; 272: G321G327.
  • 14
    Blennerhasset MG, Vignjevic P, Vermillion DL et al. Inflammation causes hyperplasia and hypertrophy in smooth muscle of rat small intestine. Am J Physiol Gastrointest Liver Physiol 1992; 262: G1041G1046.
  • 15
    Smith JW, Castro GA. Relation of peroxidase activity in gut mucosa to inflammation. Am J Physiol Regulatory Integrative Comp Physiol 1978; 235: R72R79.
  • 16
    Marzio L, Blennerhasset PA, Chiverton S, Vermillion DL, Langer J, Collins SM. Altered smooth muscle function at worm free regions in Trichinella infected rats. Am J Physiol 1990; 259: G306G313.
  • 17
    Van Rooijen N, Sanders A. Liposomes mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Meth 1994; 174: 8393.
  • 18
    Galeazzi F, Haapala EM, Van Rooijen N et al. Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. Am J Physiol Gastrointest Liver Physiol 2000; 278: G259G265.
  • 19
    Van Kaer L. Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res 2004; 30: 13953.
  • 20
    Mendiratta SK, Martin WD, Hong S et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997; 6: 46977.
  • 21
    Khan WI, Blennerhassett PA, Motomura Y et al. The role of CD1d1 in host defence in intestinal nematode infection. Gastroenterology 2004; 126: A574 (Abstract).
  • 22
    Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 16839.
  • 23
    Vallance BA, Croitoru K, Collins SM. T lymphocyte-dependent and – independent intestinal smooth muscle dysfunction in the T. spiralis-infected mouse. Am J Physiol 1998; 275: G115765.
  • 24
    Vallance BA, Galeazzi F, Collins SM, Snider DP. CD4 T cells and major histocompatibility complex class II expression influence worm expulsion and increased intestinal muscle contraction during Trichinella spiralis infection. Infection Immunity 1999; 67: 60907.
  • 25
    Mossman TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 14573.
  • 26
    McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon PG, Zurawski G, Murray R, McKenzie ANJ. Impaired development of Th2 cells in IL-13 deficient mice. Immunity; 1998; 9: 42332.
  • 27
    Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signalling mechanisms and biological functions. Annu Rev Immunol 1999; 17: 70138.
  • 28
    Takeda K, Tanaka T, Shi W et al. Essential role of Stat6 in IL-4 signalling. Nature 1996; 380: 62730.
  • 29
    Khan WI, Vallance BA, Blennerhasset PA, Deng Y, Verdue EF, Matthaei KI, Collins SM. Critical role for signal transducer and activator of transcription factor 6 in mediating intestinal muscle hypercontractility and worm expulsion in Trichinella spiralis-infected mice. Infection and Immunity 2001; 69: 83844.
  • 30
    Akiho H, Blennerhasset PA, Deng Y, Verdue EF, Matthaei KI, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2002; 282: G22632.
  • 31
    Zhao A, McDermott J, Urban JF Jr et al. Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol 2003; 171: 94854.
  • 32
    Khan WI, Richard M, Akiho H, Blennerhasset PA, Humphreys NE, Grencis RK, Van Snick J, Collins SM. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infection Immunity 2003; 71: 24308.
  • 33
    Gately MK, Renzetti LM, Magram J et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16: 495521.
  • 34
    Khan WI, Blennerhasset PA, Deng Y, Gauldie J, Vallance BA, Collins SM. IL-12 gene transfer alters gut physiology and host immunity in nematode-infected mice. Am J Physiol Gastrointest Liver Physiol 2001; 281: G102G110.
  • 35
    Grewal IS, Flavell RA. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 1996; 17: 4104.
  • 36
    Van Kooten C, Banchereau J. CD40-CD ligand. J Leukoc Biol 2000; 67: 217.
  • 37
    Khan WI, Motomura Y, Blennerhassett PA et al. Disruption of CD40-CD40 ligand pathway inhibits the development of intestinal muscle hypercontractility and protective immunity in nematode infection. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1522.
  • 38
    DeSchoolmeester ML, Little MC, Rollins BJ, Else KJ. Absence of CC chemokine ligand 2 results in an altered Th1/Th2 cytokine balance and failure to expel Trichuris muris infection. J Immunol 2003; 170: 469300.
  • 39
    Grossi L, McHugh K, Collins SM. On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology 1993; 104: 104956.
  • 40
    Khan WI, Motomura Y, Verdu EF, Blennerhasset PA, El-Sharkawy RT, Verma-Gandhu M, Collins SM. Evidence that altered motility contributes in host defence in nematode infection. Gastroenterology 2004; 126: A226 (Abstract).
  • 41
    De Jonge WJ, Van Den Wijingard RF, The Fo ter Beek ML et al. Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice. Gastroenterology 2003; 125: 113747.
  • 42
    Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil 2004; 16: 5460.
  • 43
    Mikkelsen HB, Mirsky R, Jessen KR, Thuneberg L. Macrophage-like cells in muscularis externa of mouse small intestine. immunohistochemical localization of F4/80, M1/70, and Ia–antigen. Cell Tissue Res 1988: 252: 301–6.
  • 44
    De Jonge WJ, Vander Zanden EP, The FO, Bijlsma MF et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6: 84451.
  • 45
    Kalff JC, Schraunt WH, Billiar TR, Simmons RL, Bauer AJ. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 2000; 118: 31627.
  • 46
    Hierholzer C, Kalff JC, Billiar TR, Bauer AJ, Tweardy DJ, Harbrecht BG. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 2004; 286: G22533.
  • 47
    Nakao A, Moore BA, Murase N, Liu F et al. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 2003; 52: 127885.
  • 48
    Moreels TG, De Man JG, Dick JM, Niewendijk RJ et al. Effect of TNBS-induced morphological changes on pharmacological contractility of the rat ileum. Eur J Pharmacol 2001; 423: 21122.
  • 49
    Wells RW, Blennehassetss MG. Divergent changes to muscarinic and serotonergic signalling following colitis. Gut 2005; Jul 13 [Epub ahead of print].
  • 50
    Akimoto T, Numata F, Tamura M et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT) 6-deficient mice. J Exp Med 1998; 187: 153742.
  • 51
    Ying  S, Humbert M, Barkans J et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158: 353944.
  • 52
    Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113: 122432.
  • 53
    Barbara G, De Giorgio R, Deng Y et al. Role of immunological factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfuntion in mice. Gastroenterology 2001; 120: 172936.
  • 54
    Akiho H, Deng Y, Blennehassett PA, Kanbayashi H, Collins SM. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 2005; 129: 13141.